CHM.CN Waverunner Capital Inc. (CNQ) up 900.00% Feb 21 2026: watch liquidity shift

CHM.CN stock moved sharply in market hours after a jump from C$0.005 to C$0.05, a 900.00% intraday change that flagged heavy interest in Waverunner Capital Inc. (CNQ). The move follows the June 2024 rebrand from Chemistree Technology to Waverunner Capital and appears driven by thin liquidity and low float dynamics, not new earnings. We break down valuation, trading signals, Meyka AI grade, and a model forecast to help high-volume traders understand short-term catalysts and medium-term risks for CHM.CN stock.

Intraday price action and volume context for CHM.CN stock

The main fact: CHM.CN rose to C$0.05 from a previous close of C$0.005, creating a 900.00% price change on Feb 21 2026 during market hours. Average daily volume historically is 28,908.00 shares, so a notable volume spike usually accompanies moves like this and can signal short-term liquidity swings. Traders should treat the move as a high-volume liquidity event rather than proof of fundamental change.

Valuation and financial ratios for CHM.CN stock

Waverunner Capital shows a market cap of C$37,211,650.00, EPS of -0.01, and a reported PE listed at -5.00, reflecting losses and limited operating scale. Book-value metrics show shareholders’ equity per share at -0.14, cash per share C$0.01, and a current ratio near 0.10, indicating tight short-term liquidity. These ratios underline that CHM.CN stock is a microcap with stretched fundamentals compared with Healthcare peers.

Company profile and recent corporate context for CHM.CN stock

Waverunner Capital Inc. is a North Vancouver VC-style company that rebranded in June 2024 and holds early-stage, renewable energy and biotech positions, per the company site. The firm targets equity investments between C$500,000.00 and C$1,000,000.00 and reports 744,233,000 shares outstanding, which amplifies volatility in low-volume trading. Investors should link corporate strategy to liquidity: venture holdings can be slow to convert to cash, leaving the stock exposed to headline-driven swings.

Technical and trading signals for high-volume movers: CHM.CN stock

Short-term technicals show price above the 50-day average (C$0.04) and near the 200-day average (C$0.05), a setup common after rapid spikes in microcaps. With a year high of C$0.10 and year low C$0.05, momentum traders may see intraday range trades, but low free-float and sparse volume raise execution and slippage risk. Use limit orders and monitor average volume to avoid adverse fills on CHM.CN stock.

Meyka AI grade and model outlook for CHM.CN stock

Meyka AI rates CHM.CN with a score out of 100: 64.93 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector and industry performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month base price of C$0.08, a conservative target reflecting microcap risk and sector volatility; forecasts are model-based projections and not guarantees.

Sector context and risks for CHM.CN stock

CHM.CN sits in Healthcare, an industry with mixed near-term performance and an average sector 1-day move of -3.87%, which contrasts with CHM.CN’s spike today. Key risks include negative operating cash flow per share (-0.03), a weak current ratio, and a negative book value per share, which heighten dilution and financing risk. Sector peers with stronger fundamentals highlight the valuation gap investors must weigh.

Final Thoughts

Key takeaways: CHM.CN stock posted a dramatic intraday rise to C$0.05, a 900.00% jump over the previous close, but the move looks driven by low liquidity and microcap dynamics rather than earnings or a material business update. Valuation metrics show market cap C$37,211,650.00, EPS -0.01, and strained liquidity (current ratio 0.10), all of which increase downside risk for momentum buyers. Meyka AI’s forecast model projects a 12-month base price of C$0.08, implying an upside of 60.00% from today’s price, with conservative and aggressive scenarios of C$0.04 and C$0.12 respectively; forecasts are model-based projections and not guarantees. For high-volume traders, the immediate opportunity is liquidity-driven intraday swings; for longer-term investors, the combination of negative cash flow and negative equity suggests a HOLD stance until clearer fundamentals or financing events appear. For company details, see the Waverunner Capital site and profile data on Financial Modeling Prep, and check CHM.CN real-time metrics on Meyka’s platform at https://meyka.ai/stocks/CHM.CN.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.